Tag: DrugDevelopment

• 

  Granules India Board Approves Acquisition of 100% Stake in Senn Chemicals AG for Rs 192.5 Crore

  Granules India has announced its acquisition of Senn Chemicals AG, a Swiss CDMO specializing in peptide synthesis. This move strengthens Granules' position in the rapidly growing peptide therapeutics market, particularly in the development of next-generation anti-diabetic and anti-obesity treatments. The acquisition will enhance their R&D and manufacturing capabilities, driving innovation and expanding their global reach.